The novel coronavirus outbreak makes the standard 10-year process for vaccine development untenable. Yet there is little existing data or evidence about COVID-19. To overcome this dearth, health systems caring for patients are constantly tracking and recording new data about the virus. Access to this primary source for COVID-19 near real-time patient data is vital for research teams to stay current during their life-saving work on vaccines, therapeutics, and clinical trials of all kinds. Learn more about this critical database.
Because knowledge about COVID-19 is continually evolving, the need for population-based research and real-world evidence at a national scale is critical. The most effective research includes the latest, point-of-care data that development teams can leverage to steer R&D and commercialization.
- Sadiqa Mahmood, DDS, MPH General Manager & SVP, Life Sciences Business
Health Catalyst | 3165 Millrock Dr. #400 | Salt Lake City, UT 84121 Tel: 855-309-6800
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
